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A B S T R A C T
Amyotrophic lateral sclerosis (ALS) can be associated with a spectrum of cognitive and behavioural symptoms,
but the related patterns of focal cortical atrophy in non-demented ALS patients remain largely unknown. We
enrolled 48 non-demented ALS patients and 26 healthy controls for a comprehensive neuropsychological as-
sessment and a magnetic resonance exam. Behavioural and cognitive impairment was deﬁned on the basis of a
data-driven multi-domain approach in 21 ALS patients. Averaged cortical thickness of 74 bilateral brain regions
was used as a measure of cortical atrophy. Cortical thinning in a fronto-parietal network, suggesting a disease-
speciﬁc pattern of neurodegeneration, was present in all patients, independent of cognitive and behavioural
status. Between-group and correlational analyses revealed that inferior frontal, temporal, cingular and insular
thinning are markers for cognitive and behavioural deﬁcits, with language impairment mainly related to left
temporal pole and insular involvement. These speciﬁc correlates support the concept of a spectrum of deﬁcits,
with an overlap between the ALS cognitive phenotypes and the syndromes of frontotemporal dementia.
1. Introduction
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease
characterized by the degeneration of motor neurons of the cortex, brain
stem and spinal cord, leading to progressive muscle weakness. Motor
symptoms may be accompanied by a spectrum of cognitive and beha-
vioural symptoms, ranging from mild impairment to a full-blown de-
mentia syndrome fulﬁlling the criteria for frontotemporal dementia
(FTD) (Strong et al., 2017). The neuropsychological proﬁle of non-de-
mented ALS patients is extremely heterogeneous (Montuschi et al.,
2015; Phukan et al., 2012; Strong et al., 2017; Taylor et al., 2013).
Behavioural changes (ALSbi) have been reported in ALS patients not
fulﬁlling the criteria for FTD (Consonni et al., 2013; Gibbons et al.,
2008; Lillo et al., 2011; Strong et al., 2017). Apathy is the most
frequently identiﬁed behaviour symptom in ALS (Strong et al., 2017),
but ALS patients may also present disinhibition, loss of sympathy,
perseverations and change in dietary habits (Burke et al., 2017;
Consonni et al., 2013; Gibbons et al., 2008). From a cognitive pro-
spective, deﬁcits in executive functions, language, social cognition and
memory have been observed (Beeldman et al., 2016; Boschi et al., 2017;
Carluer et al., 2015; Taylor et al., 2013). In a previous study based on
data-driven principal component analysis, we reported in non-de-
mented ALS patients a separate cognitive phenotype involving lan-
guage, social cognition and memory domains, besides dysexecutive and
behavioural impairment (Consonni et al., 2016).
The heterogeneity of cognitive proﬁles can be predicted to reﬂect
the presence of distinct patterns of involvement of cortical and sub-
cortical structures subserving behavioural and cognitive changes.
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Structural magnetic resonance imaging (MRI) studies associated with
advanced automated imaging analysis have indicated a gradient of in-
creasing cortical atrophy across the whole ALS-FTD spectrum (Agosta
et al., 2016; Leslie et al., 2015; Mioshi et al., 2013; Schuster et al.,
2014). Speciﬁcally, they documented a common pattern of atrophy of
motor and premotor cortices in all patients with ALS, extending to
frontotemporal lobes and insula when dementia is present. The brain
imaging evidence in patients with cognitive deﬁcits, not fulﬁlling the
criteria for dementia, is however limited. In some cases, ALSci patients
were classiﬁed only on the basis of executive dysfunction (Machts et al.,
2015; Mioshi et al., 2013). Only a few studies stratiﬁed ALS patients
considering also non-executive cognitive domains; the relation between
cortical atrophy and neuropsychological proﬁles was however not in-
vestigated (Christidi et al., 2012; Schuster et al., 2014). Studies ad-
dressing the correlation between cognitive and behavioural deﬁcits and
the pattern of cortical involvement have focused on speciﬁc domains.
They indicated that inferior frontal and dorsolateral prefrontal areas are
mainly related to executive dysfunction (Libon et al., 2012; Menke
et al., 2014), action naming impaired abilities (Grossman et al., 2008)
and apathy (Tsujimoto et al., 2011). Left inferior frontal and temporal
regions are related to syntactic processing (Ash et al., 2015), whereas
the anterior temporal lobe involvement reﬂects the severity of semantic
impairment (Leslie et al., 2015). Right fronto-insular and anterior cin-
gulate cortices are linked to aﬀective empathy (Cerami et al., 2014).
Hippocampal volume reduction reﬂects the severity of episodic
memory deﬁcits (Abdulla et al., 2014; Bede et al., 2013; Machts et al.,
2015; Raaphorst et al., 2015). Overall, the heterogeneity of cognitive
proﬁles might reﬂect individual cortical and subcortical signatures, a
hypothesis that we tested in a single cohort of unselected ALS patients
assessed with a comprehensive test battery.
The current study aims revealing distinctive patterns of focal cor-
tical atrophy of non-demented ALS patients and their relation to cog-
nitive phenotypes. To this aim, ALS patients were submitted to a
comprehensive neuropsychological battery for the assessment of be-
havioural changes and cognitive impairment, not restricted to executive
dysfunction but extending to language, memory, social cognition and
visuo-spatial abilities. Behavioural and cognitive proﬁles were deﬁned
on the basis of a multi-domain approach (Consonni et al., 2016). Data
of ALS patients with cognitive and/or behavioural impairment were
compared to a cohort of age-, sex- and education-matched healthy vo-
lunteers and a cohort of ALS patients with normal cognitive and be-
havioural proﬁle. Between-group analyses revealed brain regions sen-
sitive to ALS degeneration processes. Their relation to non-motor ALS
clinical proﬁles was then assessed by correlation analyses.
2. Methods
2.1. Participants
Fifty-two consecutive hospitalized patients diagnosed with probable
or deﬁnite ALS, according to El Escorial revised criteria (Brooks et al.,
2000) and 26 healthy control (HC) subjects were recruited at the Motor
Neuron Diseases Centre of the “Carlo Besta” Neurological Institute of
Milan, Italy. Exclusion criteria were comorbid frontotemporal dementia
(Rascovsky et al., 2011), Alzheimer's disease (NIA-AA), evidence of
another neurologic condition aﬀecting cognition (e.g. head trauma,
hydrocephalus, vascular disease), drug or alcohol abuse, neurocognitive
developmental disorder, primary psychiatric disorders (e.g. bipolar
disorder, major depression), other severe medical conditions and mo-
ther tongue other than Italian. Four patients satisfying inclusion criteria
were subsequently excluded by the study because of claustrophobia
during MRI scan (1) and excessive movement artefacts revealed by MRI
(3).
2.2. Materials
The revised ALS Functional Rating Scale (ALSFRS-R) was used to
assess disability. Disease duration was calculated from symptom onset
to scan date in months. Patients were assigned to ALS-cognitively im-
paired (ALSimp) versus ALS-cognitively normal (ALScn) subgroups on
the basis of a cognitive screening protocol assessing multiple cognitive
and behavioural domains (Consonni et al., 2016). Speciﬁcally, all par-
ticipants underwent a broad battery of standardized neuropsycholo-
gical tests, with published norms for the Italian population, assessing
executive functions, language, memory, social cognition and visuo-
spatial abilities (see Consonni et al., 2016, for details). At the time of
evaluation, none of the patients had dysarthria severe enough to aﬀect
naming or verbal memory recall tasks. The internal ethical review
board approved the study and each subject was enrolled after giving
written informed consent.
2.3. Patient classiﬁcation
Patients were classiﬁed following a multi-domain (MD) data-driven
analysis, based on three dimensions of non-motor manifestations in ALS
patients 1) behavioural (ALSbi), 2) dysexecutive (ALSciα), and 3) non-
executive proﬁle (ALSciβ), including language, social cognition and
episodic memory deﬁcits (Consonni et al., 2016). Brieﬂy, ALSbi char-
acterized ALS patients who did not meet full criteria for the frontal
variant of FTD, but were rated by caregivers as having at least two non-
overlapping behavioural disturbances. ALSciα patients were those
performing below cut-oﬀ on at least two of the tests tapping executive
functions. ALSciβ patients had at least two neuropsychological perfor-
mances below the normal range on non-executive measures, i.e.: lan-
guage and/or social cognition and/or episodic memory. Notably, ALSbi,
ALSciα and ALSciβ might coexist in ALS patients (Fig. 1). Our cohort
was composed of 27 patients with normal cognitive proﬁle (ALScn) and
21 with cognitive and/or behavioural impairment (ALSimp).
2.4. MRI data acquisition and MR image processing
All patients and healthy subjects underwent structural scanning,
within a week of neuropsychological assessment, on a Philips Achieva
3.0 T scanner using a 3D T1-weighted sequence (FFE, 240 sagittal slices,
TR= 9.9ms, TE=4.6ms, matrix 240×240, voxel
size= 1×1×1mm3, ﬂip angle= 8°). Cortical reconstruction and
parcellation was performed with the Freesurfer image analysis suite
(version 5.3), documented and freely available for download online
(http://surfer.nmr.mgh.harvard.edu/). The technical details of these
procedures are described in prior publications. Brieﬂy, this processing
includes removal of non-brain tissue using a hybrid watershed/surface
deformation procedure (Segonne et al., 2007) automated Talairach
transformation, intensity normalization (Sled et al., 1998), tessellation
of the grey matter (GM)/white matter (WM) boundary, automated to-
pology correction (Segonne et al., 2007) and surface deformation fol-
lowing intensity gradients to optimally place the GM/WM and GM/
cerebrospinal ﬂuid (CSF) borders at the location where the greatest
shift in intensity deﬁnes the transition to the other tissue class (Fischl
and Dale, 2000). This method uses both intensity and continuity in-
formation from the entire three dimensional MR volumes in segmen-
tation and deformation procedures to produce representations of CT,
calculated as the closest distance from the GM/WM boundary to the
GM/CSF boundary at each vertex on the tessellated GM/WM boundary
surface (Fischl and Dale, 2000). When skull stripping was leaving some
dural signal (especially in the occipital regions) in the brain mask, it
was removed manually and automatic process was recalled. For each
subject, CT values averaged on each gyral and sulcal structure were
calculated after registration to a spherical atlas which utilized in-
dividual cortical folding patterns to match cortical geometry across
subjects (Fischl et al., 1999) and automatic parcellation of the cerebral
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cortex into 74 bilateral brain regions (Destrieux et al., 2010). This ap-
proach has been shown to be a sensitive tool to detect the extra-motor
cortical involvement in ALS patients (Agosta et al., 2012).
2.5. Statistical analyses
The Kolmogorov-Smirnov test was used to test the normality of the
distribution of demographic, clinical, neuropsychological and CT data
separately for each group (ALSimp, ALScn and HC). Accordingly,
parametric and non-parametrical analyses were performed. Chi-Square,
One-way Anova and Kruskal-Wallis tests were used with demographic,
clinical and neuropsychological data. Bonferroni post hoc and Mann-
Whitney U tests were then used to test speciﬁc group comparisons:
“ALSimp vs. HC”, “ALScn vs. HC” and “ALSimp vs. ALScn”. CT varia-
bility between groups was analysed by ANCOVA, with age and total
intra-cranial volume as covariates. The eﬀect size (partial eta squared)
was also reported. Bonferroni post hoc tests were then performed for
the aforementioned group comparisons. Regions with a p value of 0.05
or lower were considered as signiﬁcant and included in correlation
analyses, with the aim to identify their relationship with ALS neu-
ropsychological and clinical proﬁles.
We computed partial correlations (correcting for age, education and
total intra-cranial volume) between CT measures of brain regions re-
sulting signiﬁcantly thinner in ALS patients than controls, and neu-
ropsychological measures showing signiﬁcant diﬀerences between ALS
and HC groups. For this purpose, standardized z scores for each CT and
neuropsychological measure were calculated by subtracting the mean
score of HC subjects from the patient's score, and then dividing the
diﬀerence by the HC group standard deviation. The same procedure
was applied to clinical data (correcting for age and total intra-cranial
volume). Signiﬁcant correlations were then bias corrected and ac-
celerated bootstrap 95% conﬁdence intervals (CIs) were computed with
1000 bootstrap equally-sized samples obtained by randomly resampling
replacement from the original data. To control for multiple testing
across cognitive measures (12), each p value underwent Bonferrroni
correction. Partial correlations with p < 0.05 and CIs not crossing “0”
surviving Bonferroni correction were reported.
3. Results
3.1. Clinical and demographic data
Descriptive statistics are summarized in Table 1. ALScn, ALSimp and
HC groups did not diﬀer in to age (F2,73= 0.252, p=0.252), gender
(X2= 4.233, p=0.809) and education (F2,73= 1.346, p= 0.267).
Disease duration (T45= 0.149, p=0.882), functional disability
assessed with ALSFRS-R (T45= 0.344, p=0.733), type of onset
(X2= 1.382, p=0.239) and Riluzole therapy (X2=2.116, p= 0.146)
were similar across ALS subgroups.
3.2. Neuropsychological data
HC and ALScn groups had similar neuropsychological performances.
The ALSimp group compared with HC and ALScn groups had lower
performances in all cognitive domains, with the only exception of
visuo-spatial performance (Table 2). Both ALS subgroups were more
depressed (higher scores) than HC subjects. Additional Spearman cor-
relations were performed between the GDS scores of ALS subgroups and
the neuropsychological performances signiﬁcantly reduced in the
comparison with the HC group. The lack of signiﬁcant correlation
suggested that defective cognitive performances were not related to
depression. In contrast, in the ALScn group, behavioural changes
measured with the dysexecutive questionnaire were related to depres-
sive mood (r= 0.429, p=0.041, CIs= 0.04–0.74).
3.3. CT region-wise data
Both ALS patient groups had CT reduction in bilateral frontal, and
left posterior cingular cortex (PCC) compared to HC individuals (Fig. 2).
ALScn patients had reduced CT in posterior regions (PCC, parietal and
occipital areas) and in the left transversal temporal gyrus. ALSimp pa-
tients showed a more widespread thinning in bilateral insula, left in-
ferior frontal gyrus, right temporal pole, and right anterior cingulate
cortex (AAC). Moreover, the direct comparisons between ALS sub-
groups revealed that ALSimp patients had a speciﬁc thinning of the
right inferior temporal gyrus and sulcus compared with ALScn patients
Fig. 1. Neuropsychological proﬁles of ALS patients ac-
cording to the MD classiﬁcation.
ALScn= cognitively-normal ALS patients; ALSbi=ALS
patients mild behavioural impairment; ALSciα=ALS
patients with mild dysexecutive impairment (with ≥2
performances below cut-oﬀ on tests addressing executive
cognitive functions); ALSciβ=ALS patients with ≥2
performances below cut-oﬀ on tests addressing non-ex-
ecutive cognitive functions (social cognition, language
and memory); ALSciα+ β=ALS patients with a mixed
cognitive proﬁle; ALSbi-ciβ=ALSbi patients with non-
executive cognitive impairment; ALSbi-ciα+ β=ALSbi
patients with the ALSci α+ β proﬁle.
Table 1
Demographic and clinical data.
HC (N=26) ALScn (N=27) ALSimp (N=21)
Age (years) 56.8 ± 9.96 58.3 ± 10.44 58.8 ± 10.76
Education (years) 11.8 ± 3.58 11.0 ± 3.84 9.6 ± 3.87
Sex (male/female) 10/16 11/16 10/11
Disease duration (months) – 21.92 ± 15.78 19.95 ± 15.28
Bulbar onset (yes/no) – 5/22 7/14
Bulbar symptoms (yes/no) – 13/14 9/12
Riluzole therapy (yes/no) – 16/11 8/13
ALSFRS-R (range 0–48) – 38.6 ± 6.87 37.7 ± 5.68
# C9ORF72 mutations n.a. 4 (2 n.a.) 2 (4 n.a.)
ALScn=ALS patients with a normal cognitive proﬁle; ALSimp=ALS patients
with behavioural and/or cognitive impairment; HC=healthy controls;
n.a.= not available data.
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(Fig. 3).
We did not ﬁnd any signiﬁcant CT reduction in HC individuals
compared with ALS subgroups. Table 3 displays further details. When
patients with a repeat expansion in the C9orf72 gene (C9+) were ex-
cluded from the analyses (i.e.: 2 ALSimp and 4 ALScn), thickness dif-
ferences for anterior and posterior cingular, subcentral, parietal and
occipital areas were no more signiﬁcant.
3.4. Correlations
In the ALScn group, longer disease duration was related to CT re-
duction in the left precentral gyrus (r=−0.414, p= 0.049, CIs:−0.69
to−0.13), whereas increased motor disability (lower ALSFRS-R scores)
was related to the thinning of the left superior circular sulcus
(r= 0.486, p=0.019, CIs: 0.16–0.70). There were no signiﬁcant cor-
relations among CT measures and clinical variables in ALSimp patients.
Signiﬁcant correlations were found between cognitive performances
and CT values in ALS patients (Table 4). Speciﬁcally, in ALScn patients
abnormal results at episodic memory were related to thinning of left
paracentral lobule and subparietal sulcus. ALSimp patients showed
strong association between impaired performances in naming and
verbal episodic memory and thinning of left temporal pole, insula and
IFG.
Table 2
Neuropsychological performances and between-group comparisons.
Neuropsychological measures HC ALScn ALSimp F/X (p value); post-hoc
M.M.S.E 29.3 ± 0.93 28.6 ± 1.32 27.4 ± 2.03 13.543 (0.001); a***
Geriatric depression scale 1.6 ± 2.73 3.8 ± 2.70 4.6 ± 3.29 17.964 (< 0.001); a***, c***
Behaviour
Frontal behavioural inventory (part A) – 1.3 ± 1.89 3.4 ± 4.54 Ns
Frontal behavioural inventory (part B) – 0.7 ± 1.24 2.6 ± 4.60 Ns
Dysexecutive questionnaire (DEX) – 5.7 ± 7.08 9.6 ± 8.42 Ns
Social cognition
SET intention attribution 5.07 ± 1.05 4.7 ± 1.12 4.2 ± 1.32 Ns
SET emotion attribution 4.9 ± 1.05 4.8 ± 1.10 3.8 ± 1.79 6.013 (0.049); a*, b*
SET causal inference 4.9 ± 0.89 4.6 ± 1.73 3.7 ± 1.58 8.341 (0.015); a***, b*
Emotion recognition (Ekman test) 46.2 ± 6.15 47.9 ± 4.23 42.0 ± 6.86 6.110 (0.004); b*
Memory
Verbal immediate recall (RAVLT) 48.8 ± 8.4 46.2 ± 8.30 37.4 ± 10.14 10.277 (< 0.001); a***, b***
Verbal delayed memory (RAVLT) 10.5 ± 2.43 9.6 ± 2.51 7.4 ± 2.96 8.029 (0.001); a***, b*
Non-verbal recognition memory 24.5 ± 3.87 23.5 ± 4.3 21.3 ± 4.85 3.196 (0.047); a*
Attention/executive functions
Digit span forward 6.1 ± 1.37 5.8 ± 0.98 5.0 ± 1.51 8.556 (0.014);a**, b*
Digit span backward 4.6 ± 1.29 4.7 ± 1.25 3.5 ± 1.20 6.255 (0.003); a**, b**
Stroop test (Stroop-eﬀect - time) 18.1 ± 7.00 19.6 ± 7.70 28.6 ± 18.71 5.252 (0.007); a*, b*
Phonemic ﬂuency (F+ P+L) 38.1 ± 9.91 34.2 ± 8.7 25.3 ± 8.71 10.824 (< 0.001); a***,b**
Phonemic ﬂuency index (F) 3.9 ± 1.44 4.7 ± 2.22 7.3 ± 4.38 8.434 (0.001); a***, b*
Brixton test 19.1 ± 7.3 20.5 ± 9.03 21.9 ± 6.69 Ns
Cognitive estimation (STEP) 41.3 ± 5.96 44.4 ± 4.95 43.2 ± 4.27 Ns
Language
Object naming (BADA) 28.5 ± 1.52 28.5 ± 1.12 25.7 ± 3.37 21.333 (< 0.001); a***, b***
Auditory sentence comprehension 13.9 ± 0.40 13.7 ± 0.49 13.5 ± 0.82 7.274 (0.26); a*
Visuo-spatial abilities
Position discrimination (VOSP) 19.6 ± 0.69 19.7 ± 0.86 19.7 ± 0.71 Ns
BADA=Batteria per l'analisi del deﬁcit afasico; RAVLT=Rey Auditory Verbal Learning test; SET= Story-based Empathy task; STEP=The Time and Weight
Estimation Test; VOSP=Visual object and space perception battery. Ns=not signiﬁcant diﬀerence; a=HC Vs. ALSimp; b=ALScn Vs. ALSimp; c=HC Vs. ALScn;
*= p < 0.05; **=p < 0.01; ***= p < 0.005.
Fig. 2. Distribution of the cortical thinning in patients with ALS considering their cognitive status. Yellow indicates thinning in ALSimp patients compared to HC
volunteers; blue indicates thinning in ALScn patients compared to HC volunteers; green indicates overlap between these comparisons. (For interpretation of the
references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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4. Discussion
We adopted a data-driven approach to identify the cognitive in-
volvement in ALS to investigate the anatomical correlates of cognitive
and behavioural proﬁles of non-demented patients (Consonni et al.,
2016). This approach diﬀers from the recently revised Strong et al.
criteria (2017) in the separation of social cognition deﬁcits from ex-
ecutive dysfunction, and in considering memory deﬁcits. We identiﬁed
a subgroup of 21 ALS patients, called ALSimp, showing a heterogeneous
set of deﬁcits encompassing behavioural (ALSbi), executive (ALSciα)
and non-executive (ALSciβ) dysfunction related to language, social
cognition and memory. In agreement with other studies (Agosta et al.,
2016), ALSimp patients showed thinning of several speciﬁc cerebral
areas besides the motor cortex. These included insula, AAC, temporal
cortex and left inferior frontal gyrus (IFG). These cortical signatures
were related to speciﬁc cognitive dysfunctions.
The thinning of the left insular cortex in the ALSimp group was
related to poor performance in non-executive cognitive measures.
Fig. 3. Distribution of the cortical thinning (in red) on the pial surface of the
right hemisphere (lateral and inferior views) in ALSimp patients compared to
ALScn patients. (For interpretation of the references to colour in this ﬁgure
legend, the reader is referred to the web version of this article.)
Table 3
CT measures and between-group comparisons.
HC (N=26) ALScn (N=27) ALSimp (N=21) F (partial eta squared) Bonferroni corrected contrasts
Frontal lobe
Right middle frontal sulcus 2.171 ± 0.12 2.056 ± 0.13 2.029 ± 0.12 9.225⁎⁎⁎ (0.211) a⁎⁎⁎, c⁎⁎⁎
Left precentral gyrus 2.657 ± 0.17 2.563 ± 0.15 2.483 ± 0.15 3.925⁎⁎⁎ (0.159) a⁎⁎⁎
Left paracentral lobule and sulcus 2.246 ± 0.13 2.089 ± 0.20 2.118 ± 0.14 6.221⁎⁎⁎ (0.153) a⁎, c⁎⁎⁎
Left pars opercularis of the IFG 2.673 ± 0.13 2.622 ± 0.12 2.545 ± 0.16 4.469⁎ (0.115) a⁎
Left precentral sulcus (inferior) 2.347 ± 0.11 2.296 ± 0.15 2.223 ± 0.20 3.732⁎ (0.098) a⁎⁎
Left subcentral lobule and sulcus§ 2.589 ± 0.23 2.431 ± 0.21 2.465 ± 0.20 3.248⁎ (0.087) c⁎
Temporal lobe
Right inferior temporal sulcus 2.321 ± 0.24 2.364 ± 0.19 2.187 ± 0.19 4.317⁎ (0.111) b⁎
Right temporal pole 3.387 ± 0.20 3.369 ± 0.22 3.205 ± 0.29 3.986⁎ (0.104) a⁎
Right inferior temporal gyrus 2.724 ± 0.19 2.797 ± 0.12 2.668 ± 0.17 3.751⁎ (0.098) b⁎
Left transverse temporal gyrus 2.380 ± 0.27 2.198 ± 0.24 2.193 ± 0.23 4.044⁎ (0.105) c⁎
Left temporal pole 3.292 ± 0.23 3.273 ± 0.21 3.123 ± 0.26 3.294⁎ (0.087) a^
Limbic lobe
Right anterior cingulate gyrus§ 2.624 ± 0.10 2.578 ± 0.13 2.519 ± 0.18 3.162⁎ (0.082) a⁎
Left post. dorsal cingulate gyrus§ 2.834 ± 0.16 2.692 ± 0.19 2.687 ± 0.22 4.651⁎ (0.119) a⁎, c⁎
Left post. ventral cingulate gyrus 2.232 ± 0.24 2.062 ± 0.27 2.073 ± 0.23 3.573⁎ (0.094) c⁎
Insula
Left superior circular sulcus 2.517 ± 0.11 2.434 ± 0.14 2.393 ± 0.15 4.960⁎⁎ (0.126) a⁎
Left lateral sulcus (vertical ramus) 2.297 ± 0.26 2.255 ± 0.26 2.110 ± 0.29 3.406⁎ (0.090) a⁎
Right lateral sulcus (horizont. ramus) 2.210 ± 0.24 2.107 ± 0.19 2.066 ± 0.20 4.402⁎ (0.113) a⁎
Parietal lobe
Left subparietal sulcus§ 2.282 ± 0.17 2.169 ± 0.15 2.173 ± 0.18 3.526⁎ (0.093) c⁎
Occipital lobe
Right superior - transverse sulci§ 1.995 ± 0.14 1.870 ± 0.15 1.911 ± 0.18 4.201⁎ (0.109) c⁎
Ns=not signiﬁcant diﬀerence; a=HC Vs. ALSimp; b=ALScn Vs. ALSimp; c=HC Vs. ALScn.
⁎ =p < 0.05.
⁎⁎ =p < 0.01.
⁎⁎⁎ =p < 0.005.
^ = uncorrected p < 0.05.
§ = not signiﬁcant between group diﬀerences when excluding ALS cases with a repeat expansion in the C9orf72 gene.
Table 4
Signiﬁcant partial correlations (and bootstrapped 95% CIs) between neu-
ropsychological performances and CT measures.
HC ALScn ALSimp
Frontal lobes
L paracentral lobule and
sulcus
– RM 0.586 (0.07; 0.85);
p=0.003
–
L pars opercularis of the
IFG
– – DR 0.710 (0.48; 0.89);
p= 0.001
Temporal lobe
L temporal pole – – N 0.682 (0.25; 0.91);
p= 0.002
DR 0.752 (0.50; 0.88);
p < 0.001
insula
L superior circular sulcus – – N 0.644 (0.26; 0.87);
p= 0.004
DR 0.659 (0.27; 0.88);
p= 0.003
Parietal lobe
L subparietal sulcus – DR 0.632(0.23; 0.82);
p=0.001
–
DR=Delayed Recall of the RAVLT; N=Naming; RM=Recognition Memory.
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Speciﬁcally, CT of the left vertical ramus of the lateral sulcus and the
left superior circular sulcus was reduced compared to the HC group.
The left vertical ramus is a perisylvian region connected to the superior
segment of the circular sulcus of the insula in two thirds of the hemi-
spheres (Destrieux et al., 2010). Because of its proximity to the pars
triangularis of the Brodmann area 45 and the insula, it may be a can-
didate region to underpin language function. In our ALSimp cohort, the
cortical thinning of the left superior circular sulcus was associated with
defective naming and verbal recall performances. This association is in
line with the pattern of neurodegeneration described in patients with
the nonﬂuent/agrammatic variant of primary progressive aphasia
(Gorno-Tempini et al., 2011; Nestor et al., 2003), suggesting that the
left insula may be a cortical signature of language impairment in ALS.
AAC thinning has been associated with a wide range of extra-motor
function impairment in ALS, including executive and socioemotional
tasks (Cerami et al., 2014; Goldstein et al., 2011; Passamonti et al.,
2013) and apathy (Woolley et al., 2011). Early diagnosed behavioural-
variant FTD patients typically present impaired emotional and social
processing, associated with selective atrophy of the ACC and frontal
insular cortices (Piguet et al., 2011; Rascovsky et al., 2011). Similarly
we demonstrated that the ACC was thinner in the ALSimp group com-
pared to healthy volunteers. While these result may be biased by the
inclusion of C9+ ALS patients (Cistaro et al., 2014), there is no con-
sensus on the involvement of ACC in the C9+ pathology (Floeter et al.,
2016; Westeneng et al., 2016).
The thinning of the IFG in the ALSimp group suggests that it could
be a further early marker of cognitive decline. IFG thinning was asso-
ciated with executive dysfunctions (Goldstein and Abrahams, 2013;
Menke et al., 2014). In our cohort, the thinning of the left pars oper-
cularis was not limited to C9+ ALS patients (Westeneng et al., 2016),
being evident also in ALSimp patients, particularly those with lower
performances at verbal recall tasks. These results suggest that the left
IFG might be functionally related to diﬀerent tasks assessing multiple
cognitive domains, and support its role in the top-down cognitive
control (Derrfuss et al., 2012), with the pars opercularis mainly in-
volved in processing verbal information.
A further marker of cognitive impairment was found in the temporal
lobes. This is one of most consistent ﬁnding in neuroimaging studies of
grey matter atrophy in ALS (Chang et al., 2005). Yoshida (2004) re-
ported marked cortical atrophy in the limbic system, including the
temporal pole, in ALS cases with dementia deﬁned at neuropathological
exam. Therefore, the temporal lobe pathology may be a marker for the
full-blown clinical picture of FTD spectrum (Lillo et al., 2012). The
direct comparisons between ALSimp and ALScn groups showed a spe-
ciﬁc thinning of the right inferior temporal cortex, which has been
previously associated with a more rapid clinical deterioration in AL-
Simp patients (Verstraete et al., 2012). On the other hand, the right
temporal pole atrophy of ALSimp patients may reﬂect the presence and
degree of semantic deﬁcit, as in the case of the semantic variant of FTD
(Leslie et al., 2015). The link between anterior temporal lobe atrophy
and semantic impairment is supported by the strength of the correla-
tions, showing a positive association between naming performances
and CT in left temporal pole. These results are in line with the view that
language dysfunction is an important component of the proﬁle of
cognitive impairment seen in ALS (Strong et al., 2017; Taylor et al.,
2013), and that omitting language assessment in the evaluation of ALS
cognitive changes may lead to underestimating speciﬁc cortical sig-
natures. The inclusion of impaired naming performance as one of the
requisites for cognitive impairment was suﬃcient to document tem-
poral pole involvement in ALSimp patients. This ﬁnding strengthens the
view that naming performance deserves major consideration, possibly
like verbal ﬂuency, in the assessment of cognitive impairment in ALS
population.
The thinning of the temporal pole cortex was also linked to verbal
episodic memory impairment in ALS patients. Correlation analyses
controlled for age and educational level showed a signiﬁcant direct
relationship between naming and delayed recall performances at the
Rey Auditory Verbal Learning Test (RAVLT) (r= 0.579, p < 0.001,
bootstrapped CIs: 0.339–0.750). Lower naming performances corre-
sponded to a reduced number of recalled words at RAVLT. In addition,
75% of ALS patients with defective performances at RAVLT delayed
recall task had naming deﬁcits, whereas only 23% of ALS patients with
naming deﬁcit had impaired performances at RAVLT delayed recall task
(data not shown). These ﬁndings suggest that the association between
thinning of the temporal pole and verbal episodic memory impairment
could be partially biased by the underlying lexico-semantic deﬁcit.
To summarize, the cortical signatures of cognitive and behavioural
impairment in non-demented ALS patients overlap those typically ob-
served in the main clinical presentations of FTD, i.e. the behavioural
variant and progressive aphasias, supporting the concept of a fronto-
temporal spectrum disorder (FTSD).
We found cortical thinning common to both ALS subgroups.
Speciﬁcally, the left paracentral lobule, considered as markers of cen-
tral motor neuron degeneration (Agosta et al., 2012; Verstraete et al.,
2012), was thinner in ALS subgroups. Surprisingly, in our ALScn
sample, the thinning of the left paracentral lobule was related to poor
visual recognition memory. The interpretation of this ﬁnding is unclear,
as the primary motor cortex has been related mainly to motor learning
(Richardson et al., 2006). ALS subgroups had also reduced CT in the
right middle frontal sulcus. Some studies reported a negative correla-
tion between ALS behavioural changes and GM volume in the right
middle frontal gyrus (Terada et al., 2016). Our analyses and previous
ﬁndings (Agosta et al., 2012) indicate instead that the reduced CT of
this region is independent of the cognitive status and clinical features. A
further cortical signature of both ALS subgroups is the thinning of the
left PCC. Although PCC thinning was suggested to occur before the
onset of ALS (Verstraete et al., 2012), its role in neurodegenerative
process remains unclear. PCC is part of the default mode network
(DMN), believed to integrate cognitive and emotional processing. Its
increased activity has been associated with greater levels of disability
and faster disease progression in ALS patients. This may reﬂect the loss
of inhibitory neurons (Chenji et al., 2016), a known component of ALS
pathology, or the increased functional recruitment of the DMN, main-
taining an eﬃcient cognitive performance in the presence of structural
injury (Agosta et al., 2013).
The inclusion of C9+ ALS patients is a potential limitation of the
study, even if the distribution of C9+ patients across ALS subgroups
was relatively symmetrical (4 C9+ ALScn and 2 C9+ ALSimp pa-
tients). Our results are in line with the view of a more widespread
cortical involvement in C9+ ALS (Westeneng et al., 2016), who showed
cortical thinning of posterior (parietal, occipital, and dPCC), ACC and
subcentral brain regions that we did not ﬁnd in C9− ALS patients.
Therefore, the presence of C9+ ALS individuals might underpin the CT
reductions of the left subparietal sulcus, the right superior and trans-
verse occipital sulci and the left subcentral cortex found in ALScn pa-
tients (Fig. 2).
Excluding the cortical regions associated with C9orf72 mutations,
the left transverse temporal gyrus and the ventral portion of the PCC
(vPCC) were thinner in ALScn patients than HC subjects. These regions
have been already reported to be abnormal in ALS (Agosta et al., 2012;
Devine et al., 2015; Westeneng et al., 2016). The signiﬁcance of the
thinning of the left transverse temporal gyrus, which contains the pri-
mary auditory cortex, is unclear. Subsequent analyses revealed that, at
an uncorrected threshold, ALSimp group had reduced CT in both left
vPCC and left transverse temporal Gyrus (data not shown) reducing the
likelihood of a speciﬁc extra-motor involvement in C9− ALScn pa-
tients.
The CT measures were related to cognitive performances in ALS
patients, including the ALScn group, but not in HC subjects. This may
depend on the approach we used to identify the cognitive correlates of
distinctive patterns of focal cortical atrophy of ALS, i.e. correlation
analyses were performed only in brain regions that were signiﬁcantly
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thinner in ALS patient groups than in the HC group. Therefore, ALSimp
patients displayed extensive cortical thinning related to their cognitive
deﬁcits. ALScn patients, by deﬁnition, had HC-like cognitive perfor-
mances but showed speciﬁc extra-motor involvement correlating with
memory scores. The thickness reduction of the left subparietal sulcus
was related to verbal episodic memory score only in ALScn patients,
including the C9-ALScn subgroup (r= 0.582, p= 0.007, bootstrapped
CIs: 0.134–0.783). This might represent an anatomical correlate of an
ALS-related sub-threshold cognitive involvement. HC subjects did not
show signiﬁcant correlations surviving Bonferroni correction, probably
due to the lower variability in CT and neuropsychological scores.
The relatively small size of our cohort may have prevented the
identiﬁcation of additional phenotypes. A larger cohort of cognitively
impaired ALS patients, with a priori clustering based on anatomical
patterns of involvement may allow the identiﬁcation of speciﬁc cortical
signatures for each neuropsychological proﬁle. A comprehensive ap-
proach to cognition and behaviour in non-demented ALS subjects with
extensive follow-up is warranted to further investigate these issues and
correlate them with clinical course and speciﬁc phenotypes aﬀecting
behaviour, social cognition and diﬀerent aspects of language perfor-
mance.
In conclusion, our results demonstrate that distinctive patterns of
focal cortical atrophy exist and diﬀerentiate non-motor clinical proﬁles
of ALS patients, in agreement with the concept of FTSD, thus linking
ALS to FTD.
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